Clinical Trials Directory

Trials / Unknown

UnknownNCT02279264

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
RightBio Metrics · Industry
Sex
All
Age
24 Weeks – 40 Weeks
Healthy volunteers
Not accepted

Summary

Objectives: 1. To validate the accuracy of pH measurements of gastric fluid by comparing the readings from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor 2. To determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG tube prior to feedings 3. To establish normative pH values for neonates

Detailed description

RightBio Metrics has developed an indicator that rapidly checks gastric pH by aspirating gastric contents into the indicator through a nasogastric (NG) or orogastric (OG), causing a color change on the indicator. The color change represents various pH levels. Most Newborn Intensive Care Units require that NG/OG placement be confirmed after initial insertion and prior to any use. The purpose of this study is to validate the accuracy of pH measurement of gastric fluid by comparing the reading from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor, and to determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG/OG tube prior to use. The gastric pH measurements will be analyzed to determine the normative pH values for neonates.

Conditions

Interventions

TypeNameDescription
DEVICERightSpot Infant pH IndicatorpH indicator

Timeline

Start date
2014-09-01
Primary completion
2014-11-01
First posted
2014-10-31
Last updated
2014-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02279264. Inclusion in this directory is not an endorsement.